Clinical Trial Update: A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II trial evaluating HLX43 in combination with HLX07 or Serplulimab for advanced or metastatic colorectal cancer (colon cancer adenocarcinoma); the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• HLX07 (HLX07)
• HLX43
• Serplulimab (serplulimab)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Colon Cancer Adenocarcinoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING